BE2015C012I2 - - Google Patents

Download PDF

Info

Publication number: BE2015C012I2
Authority: BE; Belgium

Application number

BE2015C012C

Other languages

French (fr)

Original Assignee

Almirall Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-31

Filing date

2015-02-18

Publication date

2024-10-08

2004-05-31 Priority claimed from ES200401312A external-priority patent/ES2257152B1/en

2015-02-18 Application filed by Almirall Sa filed Critical Almirall Sa

2024-10-08 Publication of BE2015C012I2 publication Critical patent/BE2015C012I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BE2015C012C 2004-05-31 2015-02-18 BE2015C012I2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
ES200401312A ES2257152B1 (en)	2004-05-31	2004-05-31	COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS.
EP2005001969		2005-02-24
GB2005000722		2005-02-25
GB2005000740		2005-02-25

Publications (1)

Publication Number	Publication Date
BE2015C012I2 true BE2015C012I2 (en)	2024-10-08

Family

ID=34968792

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2015C012C BE2015C012I2 (en)	2004-05-31	2015-02-18

Country Status (21)

Country	Link
US (2)	US20110224177A1 (en)
EP (5)	EP2210614A1 (en)
JP (1)	JP2012211183A (en)
AT (3)	ATE419011T1 (en)
AU (3)	AU2005247104B2 (en)
BE (1)	BE2015C012I2 (en)
CA (3)	CA2568571C (en)
CY (1)	CY1110829T1 (en)
DE (3)	DE602005012102D1 (en)
DK (2)	DK1905451T3 (en)
ES (2)	ES2317245T3 (en)
HR (3)	HRP20090106T3 (en)
IL (3)	IL179685A (en)
MX (3)	MXPA06013849A (en)
NZ (3)	NZ551669A (en)
PL (2)	PL1891974T3 (en)
PT (3)	PT1905451E (en)
RS (3)	RS50786B (en)
RU (3)	RU2379033C2 (en)
SI (3)	SI1891974T1 (en)
WO (3)	WO2005115465A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
WO2006085689A1 (en) *	2005-02-10	2006-08-17	Oncolys Biopharma, Inc.	Anticancer agent to be combined with telomelysin
US20100063016A1 (en) *	2007-02-19	2010-03-11	Cipla Limited	Pharmaceutical Combinations
EP2080508A1 (en) *	2008-01-15	2009-07-22	CHIESI FARMACEUTICI S.p.A.	Dry powder formulation comprising an anticholinergic drug
EP2080523A1 (en) *	2008-01-15	2009-07-22	CHIESI FARMACEUTICI S.p.A.	Compositions comprising an antimuscarinic and a long-acting beta-agonist
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
GB0811100D0 (en) *	2008-06-17	2008-07-23	Astrazeneca Ab	New combination
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
EP4403231A3 (en)	2009-02-26	2024-10-23	Glaxo Group Limited	Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2010097114A1 (en) *	2009-02-26	2010-09-02	Glaxo Group Limited	Novel combination of therapeutic agents
CA2761845C (en)	2009-05-14	2015-01-20	Tianjin Hemay Bio-Tech Co., Ltd.	Thiophene[3,4-c]pyrrole pde4 mediators
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
RU2666963C2 (en)	2012-04-13	2018-09-13	Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	Aggregated particles
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
DK2968313T3 (en) *	2013-03-15	2018-04-16	Verona Pharma Plc	drug combination
GB201308933D0 (en) *	2013-05-17	2013-07-03	Diurnal Ltd	Paediatric composition
CN110592083A (en) *	2013-07-05	2019-12-20	柏业公司	Respiratory disease related gene specific siRNA, double helix oligo RNA structure containing siRNA and application thereof
TW201542207A (en) *	2013-10-03	2015-11-16	Otsuka Pharma Co Ltd	Therapeutic agent for severe asthma

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT7920688U1 (en)	1979-02-05	1980-08-05	Chiesi Paolo	Inhaler for powdered medicinal substances, with combined dosing function
EP0069715B1 (en)	1981-07-08	1986-11-05	Aktiebolaget Draco	Powder inhalator
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FI69963C (en)	1984-10-04	1986-09-12	Orion Yhtymae Oy	DOSERINGSANORDNING
DE3927170A1 (en)	1989-08-17	1991-02-21	Boehringer Ingelheim Kg	INHALATOR
IT1237118B (en)	1989-10-27	1993-05-18	Miat Spa	MULTI-DOSE INHALER FOR POWDER DRUGS.
US5201308A (en)	1990-02-14	1993-04-13	Newhouse Michael T	Powder inhaler
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
GB9015522D0 (en)	1990-07-13	1990-08-29	Braithwaite Philip W	Inhaler
WO1992003175A1 (en)	1990-08-11	1992-03-05	Fisons Plc	Inhalation device
DE4027391A1 (en)	1990-08-30	1992-03-12	Boehringer Ingelheim Kg	GAS-FREE INHALATION DEVICE
ATE164525T1 (en)	1990-09-26	1998-04-15	Pharmachemie Bv	INHALER WITH A RESERVOIR FOR SEVERAL DOSED INHALATION AGENTS, WITH TRANSPORT DEVICE AND WITH VOLTAGE CHAMBER
GB9026025D0 (en)	1990-11-29	1991-01-16	Boehringer Ingelheim Kg	Inhalation device
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
DE4239402A1 (en)	1992-11-24	1994-05-26	Bayer Ag	Multiple dosage powder inhaler - has acceleration channel and dwell chamber for uniformly high drug dispersion
JP2924924B2 (en)	1992-12-18	1999-07-26	シェリング・コーポレーション	Inhaler for powdered drugs
US5837699A (en) *	1994-01-27	1998-11-17	Schering Corporation	Use of mometasone furoate for treating upper airway passage diseases
EP1547636A1 (en)	1995-04-14	2005-06-29	SmithKline Beecham Corporation	Metered dose inhaler for salmeterol
BR9608997A (en)	1995-06-21	1999-06-29	Asta Medica Ag	Pharmaceutical powder cartridge with integrated measuring device and powder medicine installer
DE19528145A1 (en) *	1995-08-01	1997-02-06	Boehringer Ingelheim Kg	New drugs and their use
DE19536902A1 (en)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
ES2165768B1 (en) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0009606D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Therapeutic combinations
GB0009605D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Medicaments
GB0009583D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory formulations
GB0009592D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory combinations
EP1318973A2 (en) *	2000-09-22	2003-06-18	Glaxo Group Limited	Novel alkanoic acid derivatives
JP2004512359A (en)	2000-10-31	2004-04-22	ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト	Novel pharmaceutical compositions based on anticholinergics and corticosteroids
DE10062712A1 (en)	2000-12-15	2002-06-20	Boehringer Ingelheim Pharma	New drug compositions based on anticholinergics and corticosteroids
DE10056104A1 (en) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts
SK287414B6 (en) *	2000-12-28	2010-09-07	Laboratorios Almirall, S.A.	Quinuclidine derivatives and compositions contain thereof
ES2276942T3 (en) *	2001-05-25	2007-07-01	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	COMBINATION OF A PDE4 AND TIOTROPE INHIBITOR OR A DERIVATIVE OF THE SAME TO TREAT OBSTRUCTIVE RESPIRATORY ROADS AND OTHER INFLAMMATORY DISEASES.
DE10130371A1 (en) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	New drug compositions based on anticholinergics, corticosteroids and betamimetics
ES2206021B1 (en) *	2002-04-16	2005-08-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF PIRROLIDINIO.
ES2195785B1 (en)	2002-05-16	2005-03-16	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA.
DK1507558T3 (en) *	2002-05-17	2011-12-05	Novartis Pharma Ag	Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
BR0311747A (en) *	2002-06-12	2005-06-07	Epigenesis Pharmaceuticals Inc	Pharmaceutical composition, single or multiple dose form of composition, kit, and method for treating disease
ES2211315B1 (en)	2002-11-12	2005-10-16	Almirall Prodesfarma, S.A.	NEW TRICYCLE COMPOUNDS.
ES2211344B1 (en)	2002-12-26	2005-10-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA.
PE20040950A1 (en) *	2003-02-14	2005-01-01	Theravance Inc	BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
WO2004084897A1 (en) *	2003-03-28	2004-10-07	Altana Pharma Ag	Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
WO2004084896A1 (en) *	2003-03-28	2004-10-07	Altana Pharma Ag	Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
ES2257152B1 (en) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS.

2005
- 2005-05-31 RS RSP-2009/0075A patent/RS50786B/en unknown
- 2005-05-31 DE DE602005012102T patent/DE602005012102D1/en not_active Expired - Lifetime
- 2005-05-31 PT PT07023760T patent/PT1905451E/en unknown
- 2005-05-31 EP EP10003385A patent/EP2210614A1/en not_active Withdrawn
- 2005-05-31 PT PT07019646T patent/PT1891974E/en unknown
- 2005-05-31 RU RU2006146673/15A patent/RU2379033C2/en not_active IP Right Cessation
- 2005-05-31 AT AT05748688T patent/ATE419011T1/en active
- 2005-05-31 SI SI200531128T patent/SI1891974T1/en unknown
- 2005-05-31 WO PCT/EP2005/005839 patent/WO2005115465A1/en not_active Ceased
- 2005-05-31 EP EP07019646A patent/EP1891974B1/en not_active Expired - Lifetime
- 2005-05-31 PT PT05748688T patent/PT1765404E/en unknown
- 2005-05-31 ES ES05748688T patent/ES2317245T3/en not_active Expired - Lifetime
- 2005-05-31 AU AU2005247104A patent/AU2005247104B2/en not_active Ceased
- 2005-05-31 AU AU2005247105A patent/AU2005247105B2/en not_active Ceased
- 2005-05-31 DK DK07023760.7T patent/DK1905451T3/en active
- 2005-05-31 WO PCT/EP2005/005837 patent/WO2005115463A1/en not_active Ceased
- 2005-05-31 RS RSP-2010/0104A patent/RS51206B/en unknown
- 2005-05-31 MX MXPA06013849A patent/MXPA06013849A/en active IP Right Grant
- 2005-05-31 NZ NZ551669A patent/NZ551669A/en not_active IP Right Cessation
- 2005-05-31 NZ NZ551666A patent/NZ551666A/en not_active IP Right Cessation
- 2005-05-31 HR HR20090106T patent/HRP20090106T3/en unknown
- 2005-05-31 SI SI200530599T patent/SI1765404T1/en unknown
- 2005-05-31 DE DE602005022499T patent/DE602005022499D1/en not_active Expired - Lifetime
- 2005-05-31 AT AT07023760T patent/ATE454904T1/en active
- 2005-05-31 EP EP07023760A patent/EP1905451B1/en not_active Expired - Lifetime
- 2005-05-31 NZ NZ551670A patent/NZ551670A/en not_active IP Right Cessation
- 2005-05-31 AT AT07019646T patent/ATE474601T1/en active
- 2005-05-31 PL PL07019646T patent/PL1891974T3/en unknown
- 2005-05-31 RU RU2006146813/15A patent/RU2385156C2/en not_active IP Right Cessation
- 2005-05-31 WO PCT/EP2005/005838 patent/WO2005115464A1/en not_active Ceased
- 2005-05-31 MX MXPA06013850A patent/MXPA06013850A/en active IP Right Grant
- 2005-05-31 EP EP05759006A patent/EP1765405A1/en not_active Withdrawn
- 2005-05-31 MX MXPA06013846A patent/MXPA06013846A/en active IP Right Grant
- 2005-05-31 CA CA2568571A patent/CA2568571C/en not_active Expired - Fee Related
- 2005-05-31 SI SI200530959T patent/SI1905451T1/en unknown
- 2005-05-31 RU RU2006147269/15A patent/RU2404772C2/en not_active IP Right Cessation
- 2005-05-31 RS RSP-2010/0379A patent/RS51422B/en unknown
- 2005-05-31 DK DK07019646.4T patent/DK1891974T3/en active
- 2005-05-31 AU AU2005247106A patent/AU2005247106B2/en not_active Ceased
- 2005-05-31 CA CA2568568A patent/CA2568568C/en not_active Expired - Fee Related
- 2005-05-31 PL PL07023760T patent/PL1905451T3/en unknown
- 2005-05-31 EP EP05746222A patent/EP1761279A1/en not_active Withdrawn
- 2005-05-31 DE DE602005018969T patent/DE602005018969D1/en not_active Expired - Lifetime
- 2005-05-31 CA CA2569074A patent/CA2569074C/en not_active Expired - Fee Related
- 2005-05-31 ES ES07023760T patent/ES2336144T3/en not_active Expired - Lifetime
2006
- 2006-11-29 IL IL179685A patent/IL179685A/en not_active IP Right Cessation
- 2006-11-29 IL IL179686A patent/IL179686A0/en unknown
- 2006-11-29 IL IL179690A patent/IL179690A/en not_active IP Right Cessation
2010
- 2010-02-26 HR HR20100104T patent/HRP20100104T1/en unknown
- 2010-09-03 HR HR20100490T patent/HRP20100490T1/en unknown
- 2010-10-11 CY CY20101100905T patent/CY1110829T1/en unknown
2011
- 2011-03-14 US US13/047,039 patent/US20110224177A1/en not_active Abandoned
2012
- 2012-07-06 JP JP2012152730A patent/JP2012211183A/en active Pending
- 2012-09-05 US US13/603,985 patent/US20130196961A1/en not_active Abandoned
2015
- 2015-02-18 BE BE2015C012C patent/BE2015C012I2/fr unknown

Also Published As

Publication number	Publication date
RU2006146813A (en)	2008-07-20
PT1905451E (en)	2010-03-31
MXPA06013849A (en)	2007-03-01
MXPA06013846A (en)	2007-03-01
RS50786B (en)	2010-08-31
EP1891974A1 (en)	2008-02-27
CY1110829T1 (en)	2015-06-10
IL179685A0 (en)	2007-05-15
NZ551669A (en)	2010-07-30
WO2005115465A1 (en)	2005-12-08
EP1765405A1 (en)	2007-03-28
DE602005022499D1 (en)	2010-09-02
AU2005247104B2 (en)	2010-11-11
ES2336144T3 (en)	2010-04-08
CA2569074A1 (en)	2005-12-08
NZ551666A (en)	2010-07-30
PL1891974T3 (en)	2010-12-31
EP1905451A1 (en)	2008-04-02
EP1891974B1 (en)	2010-07-21
CA2568571C (en)	2012-12-18
ATE454904T1 (en)	2010-01-15
ES2317245T3 (en)	2009-04-16
RU2006146673A (en)	2008-07-20
DE602005018969D1 (en)	2010-03-04
CA2569074C (en)	2012-12-18
DK1905451T3 (en)	2010-05-10
MXPA06013850A (en)	2007-03-02
ATE474601T1 (en)	2010-08-15
RS51422B (en)	2011-02-28
HRP20100490T1 (en)	2010-10-31
AU2005247105B2 (en)	2010-11-11
IL179690A0 (en)	2007-05-15
RU2404772C2 (en)	2010-11-27
SI1905451T1 (en)	2010-05-31
WO2005115463A1 (en)	2005-12-08
IL179686A0 (en)	2007-05-15
JP2012211183A (en)	2012-11-01
IL179685A (en)	2012-01-31
SI1765404T1 (en)	2009-04-30
HK1096605A1 (en)	2007-06-08
PT1765404E (en)	2009-03-31
IL179690A (en)	2012-10-31
PL1905451T3 (en)	2010-05-31
AU2005247105A1 (en)	2005-12-08
CA2568571A1 (en)	2005-12-08
CA2568568A1 (en)	2005-12-08
US20110224177A1 (en)	2011-09-15
EP1905451B1 (en)	2010-01-13
DK1891974T3 (en)	2010-11-08
RU2006147269A (en)	2008-07-20
SI1891974T1 (en)	2010-11-30
AU2005247106A1 (en)	2005-12-08
HRP20090106T3 (en)	2009-03-31
EP2210614A1 (en)	2010-07-28
RU2385156C2 (en)	2010-03-27
RS51206B (en)	2010-12-31
HRP20100104T1 (en)	2010-04-30
AU2005247104A1 (en)	2005-12-08
DE602005012102D1 (en)	2009-02-12
EP1761279A1 (en)	2007-03-14
CA2568568C (en)	2012-12-18
PT1891974E (en)	2010-09-27
ATE419011T1 (en)	2009-01-15
AU2005247106B2 (en)	2010-11-11
NZ551670A (en)	2010-07-30
US20130196961A1 (en)	2013-08-01
RU2379033C2 (en)	2010-01-20
WO2005115464A1 (en)	2005-12-08

Publication	Publication Date	Title
BE2024C508I2 (en)	2024-08-08
BE2023C542I2 (en)	2025-02-07
BE2022C549I2 (en)	2024-08-08
BE2021C001I2 (en)	2025-02-11
BE2020C513I2 (en)	2024-08-08
BE2020C517I2 (en)	2024-08-08
BE2019C540I2 (en)	2024-08-08
BE2019C523I2 (en)	2025-02-10
BE2019C548I2 (en)	2024-10-09
BE2019C506I2 (en)	2025-04-23
BE2018C045I2 (en)	2024-08-08
BE2020C525I2 (en)	2025-02-11
BE2017C063I2 (en)	2025-02-07
BE2017C027I2 (en)	2024-08-08
BE2017C023I2 (en)	2024-08-08
BE2017C002I2 (en)	2024-08-08
BE2016C067I2 (en)	2024-08-08
BE2016C014I2 (en)	2024-10-09
BE2015C041I2 (en)	2024-10-08
BE2015C038I2 (en)	2019-10-23
BE2015C014I2 (en)	2024-08-08
BE2014C071I2 (en)	2024-10-08
BE2015C015I2 (en)	2025-04-29
BE2014C064I2 (en)	2024-08-08
BE2014C063I2 (en)	2024-08-08